PlainPharmaWatch

CMS Open Payments · Program Year 2024

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals reported $13,990,298.03 in payments to 19,606 physicians and teaching hospitals across 20,808 transactions.

See the rankings → How this is sourced
$14.0M
Total payments
20,808
Transactions
19,606
Recipients
#133
of 1,925 companies

Madrigal Pharmaceuticals reported $13,990,298.03 in payments to 19,606 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #133 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $713.57 per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Madrigal Pharmaceuticals pairs top-10% payment volume with an unusually diversified payment pattern across a wide recipient base.

#133
of 1,925 companies
0.1%
of all US industry payments
0.0%
paid to its single top recipient
8
payment categories

How Madrigal Pharmaceuticals ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Madrigal Pharmaceuticals's total vs. every reporting company

CMS Open Payments, Program Year 2024

$13,990,298 Top 7% higher than 93% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Madrigal Pharmaceuticals

In Program Year 2024, Madrigal Pharmaceuticals reported $13,990,298.03 in payments to 19,606 physicians and teaching hospitals across 20,808 individual transactions, an average of $672.35 per transaction and $713.57 per recipient. That total places Madrigal Pharmaceuticals at rank #133 out of 1,925 companies in the CMS Open Payments database, representing 0.1% of all industry payments reported nationwide for the year.

Of the 8 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $3.0M across 1,071 transactions, 21.6% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 8 types of general payments, Madrigal Pharmaceuticals's largest category was "Compensation for Services Other Than Consulting" at $3.0M - 21.6% of the company's reported total.

How Madrigal Pharmaceuticals divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$3.0M2. Food and Beverage$774.1K3. Travel and Lodging$367.2K4. Honoraria$238.1K5. Consulting Fee$41.2K6. Space Rental or Facility …$40.8K7. Education$6.0K8. Grant$5.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $3.0M 1,071
Food and Beverage $774.1K 17,111
Travel and Lodging $367.2K 1,140
Honoraria $238.1K 68
Consulting Fee $41.2K 66
Space Rental or Facility Fees $40.8K 7
Education $6.0K 141
Grant $5.0K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $381,665.20 (8.5%) of $4,487,923.64 in this company's General Payments records across 8,963 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Madrigal Pharmaceuticals

The five named recipients with the highest reported General Payments from this company

Santiago Munoz$108.3KZahid Vahora$86.2KNaim Alkhouri$80.3KJulio Gutierrez$53.7KNadege Gunn$53.2K
  1. 1

    Santiago Munoz

    $108,335.69 across 94 reported transactions

  2. 2

    Zahid Vahora

    $86,245.77 across 61 reported transactions

  3. 3

    Naim Alkhouri

    $80,263.56 across 53 reported transactions

  4. 4

    Julio Gutierrez

    $53,664.69 across 45 reported transactions

  5. 5

    Nadege Gunn

    $53,155.49 across 54 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $672.35. Average per recipient: $713.57.

Total Amount

$13,990,298.03

Avg per Transaction

$672.35

Avg per Recipient

$713.57

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Madrigal Pharmaceuticals Share

0.1%

#133 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Madrigal Pharmaceuticals

Argenx US, Inc.

$14.1M 19,529 recipients

Atricure, Inc.

$13.7M 28,870 recipients

Lazurite Inc.

$13.6M 7 recipients

Centinel Spine, LLC

$13.6M 858 recipients

NovApproach Spine, LLC

$14.5M 178 recipients

RxSight Inc

$14.5M 7,552 recipients

Frequently Asked Questions

How much did Madrigal Pharmaceuticals pay to physicians and hospitals in 2024? ▾
Madrigal Pharmaceuticals made $13,990,298.03 in payments to physicians and hospitals in Program Year 2024, across 20,808 individual transactions. This represents 0.1% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Madrigal Pharmaceuticals? ▾
19,606 physicians and teaching hospitals received payments from Madrigal Pharmaceuticals in 2024, averaging $713.57 per recipient.
What types of payments did Madrigal Pharmaceuticals make? ▾
General payments from Madrigal Pharmaceuticals span 8 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $3.0M, representing 21.6% of the company's reported total.
How does Madrigal Pharmaceuticals rank among pharmaceutical companies? ▾
Madrigal Pharmaceuticals ranks #133 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Madrigal Pharmaceuticals? ▾
The average transaction from Madrigal Pharmaceuticals was $672.35 in 2024. The company made 20,808 total transactions to 19,606 recipients.
Where does the payment data for Madrigal Pharmaceuticals come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Madrigal Pharmaceuticals's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.